Nivolumab vs Trimethoprim

## Nivolumab vs Trimethoprim: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Trimethoprim**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Trimethoprim**: Dihydrofolate reductase inhibitor (bacterial selective).

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Trimethoprim — 8-10 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Trimethoprim — C14H18N4O3.

**Molecular Weight**: Nivolumab — N/A; Trimethoprim — 290.3180 g/mol.

**Type**: Nivolumab — Antibody; Trimethoprim — Small molecule.